Payments to Acquire Property, Plant, and Equipment of UNITED THERAPEUTICS Corp from 31 Mar 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
UNITED THERAPEUTICS Corp annual and quarterly Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Mar 2010 to 31 Dec 2025.
  • UNITED THERAPEUTICS Corp Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2025 was $74,900,000, a 96% increase year-over-year.
  • UNITED THERAPEUTICS Corp annual Payments to Acquire Property, Plant, and Equipment for 2025 was $520,500,000, a 111% increase from 2024.
  • UNITED THERAPEUTICS Corp annual Payments to Acquire Property, Plant, and Equipment for 2024 was $246,500,000, a 7% increase from 2023.
  • UNITED THERAPEUTICS Corp annual Payments to Acquire Property, Plant, and Equipment for 2023 was $230,400,000, a 66% increase from 2022.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)

UNITED THERAPEUTICS Corp Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $520,500,000 +$274,000,000 +111% 01 Jan 2025 31 Dec 2025 10-K 25 Feb 2026 2025 FY
2024 $246,500,000 +$16,100,000 +7% 01 Jan 2024 31 Dec 2024 10-K 25 Feb 2026 2025 FY
2023 $230,400,000 +$91,600,000 +66% 01 Jan 2023 31 Dec 2023 10-K 25 Feb 2026 2025 FY
2022 $138,800,000 +$18,000,000 +15% 01 Jan 2022 31 Dec 2022 10-K 26 Feb 2025 2024 FY
2021 $120,800,000 +$61,500,000 +104% 01 Jan 2021 31 Dec 2021 10-K 21 Feb 2024 2023 FY
2020 $59,300,000 -$24,400,000 -29% 01 Jan 2020 31 Dec 2020 10-K 22 Feb 2023 2022 FY
2019 $83,700,000 -$100,700,000 -55% 01 Jan 2019 31 Dec 2019 10-K 24 Feb 2022 2021 FY
2018 $184,400,000 +$98,100,000 +114% 01 Jan 2018 31 Dec 2018 10-K 24 Feb 2021 2020 FY
2017 $86,300,000 +$48,300,000 +127% 01 Jan 2017 31 Dec 2017 10-K 26 Feb 2020 2019 FY
2016 $38,000,000 -$11,800,000 -24% 01 Jan 2016 31 Dec 2016 10-K 27 Feb 2019 2018 FY
2015 $49,800,000 +$2,400,000 +5.1% 01 Jan 2015 31 Dec 2015 10-K 21 Feb 2018 2017 FY
2014 $47,400,000 +$15,490,000 +49% 01 Jan 2014 31 Dec 2014 10-K 22 Feb 2017 2016 FY
2013 $31,910,000 -$79,995,000 -71% 01 Jan 2013 31 Dec 2013 10-K 25 Feb 2016 2015 FY
2012 $111,905,000 +$75,927,000 +211% 01 Jan 2012 31 Dec 2012 10-K 24 Feb 2015 2014 FY
2011 $35,978,000 +$17,338,000 +93% 01 Jan 2011 31 Dec 2011 10-K 25 Feb 2014 2013 FY
2010 $18,640,000 01 Jan 2010 31 Dec 2010 10-K 26 Feb 2013 2012 FY

UNITED THERAPEUTICS Corp Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $74,900,000 +$36,700,000 +96% 01 Jan 2025 31 Mar 2025 10-Q 30 Apr 2025 2025 Q1
Q1 2024 $38,200,000 -$3,100,000 -7.5% 01 Jan 2024 31 Mar 2024 10-Q 30 Apr 2025 2025 Q1
Q1 2023 $41,300,000 +$27,800,000 +206% 01 Jan 2023 31 Mar 2023 10-Q 01 May 2024 2024 Q1
Q1 2022 $13,500,000 +$2,900,000 +27% 01 Jan 2022 31 Mar 2022 10-Q 03 May 2023 2023 Q1
Q1 2021 $10,600,000 -$2,400,000 -18% 01 Jan 2021 31 Mar 2021 10-Q 04 May 2022 2022 Q1
Q1 2020 $13,000,000 -$12,100,000 -48% 01 Jan 2020 31 Mar 2020 10-Q 05 May 2021 2021 Q1
Q1 2019 $25,100,000 -$12,500,000 -33% 01 Jan 2019 31 Mar 2019 10-Q 29 Apr 2020 2020 Q1
Q1 2018 $37,600,000 +$22,000,000 +141% 01 Jan 2018 31 Mar 2018 10-Q 01 May 2019 2019 Q1
Q1 2017 $15,600,000 +$11,800,000 +311% 01 Jan 2017 31 Mar 2017 10-Q 02 May 2018 2018 Q1
Q1 2016 $3,800,000 -$200,000 -5% 01 Jan 2016 31 Mar 2016 10-Q 26 Apr 2017 2017 Q1
Q1 2015 $4,000,000 -$14,676,000 -79% 01 Jan 2015 31 Mar 2015 10-Q 28 Apr 2016 2016 Q1
Q1 2014 $18,676,000 +$14,433,000 +340% 01 Jan 2014 31 Mar 2014 10-Q 28 Apr 2015 2015 Q1
Q1 2013 $4,243,000 -$36,039,000 -89% 01 Jan 2013 31 Mar 2013 10-Q 29 Apr 2014 2014 Q1
Q1 2012 $40,282,000 +$33,946,000 +536% 01 Jan 2012 31 Mar 2012 10-Q 25 Apr 2013 2013 Q1
Q1 2011 $6,336,000 -$26,000 -0.41% 01 Jan 2011 31 Mar 2011 10-Q 26 Apr 2012 2012 Q1
Q1 2010 $6,362,000 01 Jan 2010 31 Mar 2010 10-Q 28 Apr 2011 2011 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.